Displaying drugs 251 - 275 of 332 in total
3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE
Experimental
H-89
Experimental
CRA_9678
Experimental
3-Bromo-7-Nitroindazole
Experimental
Ranirestat
Ranirestat is a structurally novel and stereospecifically potent aldose reductase (AKR1B; EC 1.1.1.21) inhibitor, which contains a succinimide ring that undergoes ring-opening at physiological pH levels. It has been used in trials studying the treatment of Mild to Moderate Diabetic Sensorimotor Polyneuropathy.
Investigational
Rabusertib
Rabusertib has been used in trials studying the treatment of Cancer, Solid Tumors, Advanced Cancer, Pancreatic Neoplasms, and Non Small Cell Lung Cancer.
Investigational
CRA_16847
Experimental
CGI-1842
JI-101 has been used in trials studying the treatment of Cancer, Colon Cancer, Neuroendocrine, Ovarian Cancer, and Advanced Solid Tumors.
Investigational
Eosin
Experimental
Brostallicin
Investigational
Bromopride
Bromopride is a dopamine antagonist used as an antiemetic. Its prokinetic properties are similar to those of metoclopramide. It is unavailable in America or the United Kingdom.
Investigational
CP-547632
CP-547632 has been used in trials studying the treatment of Ovarian Cancer, Lung Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, and Fallopian Tube Cancer, among others.
Investigational
Hymenialdisine
Experimental
(R)-minalrestat
Experimental
S-(4-BROMOBENZYL)CYSTEINE
Experimental
Displaying drugs 251 - 275 of 332 in total